Conjunctival Commensal Isolation and Identification in Mice
May 1st, 2021
3.7K views
Presented here is a protocol for the isolation and amplification of aerobic and facultative anaerobic mouse conjunctival commensal bacteria using a unique eye swab and culture-based enrichment step with subsequent identification by microbiological based methods and MALDI-TOF mass spectrometry.
Overview
This protocol outlines a method for isolating and amplifying aerobic and facultative anaerobic mouse conjunctival commensal bacteria. It employs a unique eye swab and culture-based enrichment step, followed by identification using microbiological methods and MALDI-TOF mass spectrometry.
Key Study Components
Area of Science
- Microbiology
- Ophthalmology
- Commensal Bacteria
Background
- Identifying viable ocular conjunctival microorganisms is challenging due to the eye's hostile environment.
- This method focuses on viable microorganisms, providing a clearer understanding of the ocular commensal community.
- Unique bacterial signatures may be associated with difficult-to-diagnose eye diseases.
- The method contrasts with DNA sequencing, which detects both viable and non-viable microorganisms.
Purpose of Study
- To determine the existence of an ocular microbiome.
- To investigate how bacterial presence changes in eye disease.
- To develop a diagnostic method for eye diseases based on microbial signatures.
Methods Used
- Autoclaving cotton batting and toothpicks for swabbing mice.
- Swabbing the conjunctival area of mice with prepared cotton batting.
- Culture-based enrichment of isolated bacteria.
- Identification of bacteria using MALDI-TOF mass spectrometry.
Main Results
- Viable microorganisms were successfully identified from mouse conjunctival samples.
- The method provided insights into the ocular commensal community.
- Potential links between bacterial presence and eye diseases were suggested.
- This approach may enhance the diagnosis of eye diseases with distinctive microbial signatures.
Conclusions
- The protocol effectively isolates and identifies viable ocular microorganisms.
- It offers a clearer understanding of the ocular microbiome compared to traditional methods.
- This method could be pivotal in diagnosing eye diseases based on microbial profiles.
Frequently Asked Questions
What is the significance of studying ocular microbiomes?
Studying ocular microbiomes can help understand their role in eye health and disease.
How does this method differ from DNA sequencing?
This method identifies only viable microorganisms, while DNA sequencing detects both viable and non-viable ones.
What diseases could this method help diagnose?
It may help diagnose eye diseases with unique microbial signatures, including autoimmune conditions.
What are the key steps in the protocol?
Key steps include autoclaving materials, swabbing, culturing, and identifying bacteria.
Can this method be applied to other species?
While this study focuses on mice, similar methods could potentially be adapted for other species.
What is MALDI-TOF mass spectrometry?
MALDI-TOF mass spectrometry is a technique used for identifying microorganisms based on their mass spectra.
Executive Industry Relevance
Isolating viable ocular commensal bacteria enables target validation in preclinical models of eye disease by providing a disease-relevant system to monitor microbial shifts. This method supports mechanistic de-risking by distinguishing live from dead microorganisms, improving predictive confidence in biomarker discovery. It positions microbiological profiling as a translational tool for de-risking therapeutic hypotheses in ophthalmology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by isolating viable conjunctival microorganisms under different disease conditions.
- Operational Value: Provides a culture-based method to define commensal diversity in mice, supporting biological de-risking of ocular targets.
- Predictive Value: Supports portfolio triage by linking microbial signatures to disease states, improving target confidence.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream workflows by enriching aerobic and facultative anaerobic genera from ocular samples.
- Operational Value: Addresses assay standardization and reproducibility through a swab-based technique with controlled enrichment and plating steps.
- Scalability: Highlights platform reuse potential for monitoring microbial shifts across experimental groups and disease models.
Translational & Preclinical Research
- Scientific Value: Discusses disease relevance by linking unique bacterial presence to difficult-to-diagnose eye diseases such as autoimmune and non-autoimmune dry eye.
- Operational Value: Describes continuity from discovery through preclinical validation by enabling longitudinal monitoring of ocular microbiota.
- Risk-Adjusted Advancement: Supports decisions based on microbial signatures, aligning with translational biomarker alignment strategies.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from hypothesis testing in early discovery to preclinical validation, supporting lead identification through microbial profiling.
- Discovery Biology: Explains how the method supports hypothesis testing by isolating viable microorganisms to clarify pathway involvement in ocular surface immunity.
- Screening: Describes assay readiness through culture-based enrichment and quantitative outputs like colony forming units per swab.
- Analytics: Highlights measurements such as morphology, relative abundance, and MALDI-TOF MS identification that help teams compare conditions across groups.
- Translational Research: Connects the method to preclinical continuity by enabling monitoring of microbial changes in disease models, supporting biomarker alignment.
- Enterprise Reuse: Frames the method as a reusable capability for microbiological profiling across ocular disease models, not a single-use technique.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in ocular microbiome studies.
- Operational Value: Standardization, reproducibility, and scalability of viable bacterial isolation from low-abundance ocular samples.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk in ophthalmology programs.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on microbial signatures linked to disease phenotypes.
Implementation Considerations
- Required scientific expertise in microbiological techniques, anaerobic culture handling, and MALDI-TOF MS operation.
- Instrumentation and analytical infrastructure needs include autoclave, incubator, plating equipment, and mass spectrometry for identification.
- Cross-team standardization requirements for swab preparation, enrichment timing, and plating consistency across users.
- Adaptation considerations across model systems, including potential adjustments for different species or ocular surface accessibility.
- Practical limitations supported by source material: low recoverable bacteria, occasional failure to yield isolates, and dependence on proper swabbing technique.
Biopharma FAQs
Why does viable microorganism isolation matter for target validation?
Isolating only viable microorganisms provides a clearer understanding of the ocular commensal community, avoiding aberrant representation from dead cells. This supports accurate target validation by reflecting true biological presence in disease models.
How does swab-based enrichment fit the discovery pipeline?
The swab-based technique enriches aerobic and facultative anaerobic genera from ocular samples, preparing validated biological systems for downstream workflows. This enables reliable compound evaluation and screening readiness in preclinical programs.
What do quantitative dependent variable measurements enable?
Measuring colony forming units per swab and relative abundance allows teams to compare microbial shifts across conditions. These quantitative outputs support hypothesis testing and biomarker discovery in eye disease models.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures consistency in swabbing, enrichment, and plating steps, which is essential for reproducible results across teams. Standardized protocols enable reliable data sharing between discovery and translational groups.
What statistical analysis capabilities are required before implementation?
Teams need capabilities to analyze colony counts, morphology, and relative abundance data to determine significant differences between groups. Basic statistical comparison of microbial levels supports go/no-go decisions in target validation.
